Translate Bio is the amalgamation of two passionate teams of scientists with one shared mission: to transform RNA science into revolutionary medicines.
Our story begins in a lab in 2008 in Lexington, Mass, where a skilled group of researchers was developing a technology to test whether messenger RNA could be used to treat a wide range of diseases.
Fast forward to 2011, when a small Cambridge, Mass, biotech company called RaNA Therapeutics was founded to discover and develop methods of treating genetic disease by modulating the actions of long non-coding RNA.
In 2017, these two groups joined together to form Translate Bio. Representing a decade of RNA expertise and know-how, we are now a leading RNA therapeutics company using the body’s own machinery to produce proteins and transformative medicines to combat disease from within.